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ABSTRACT
Rapid advances in microarray technologies and the related computational analyses have led to a paradigm
shift in biological investigation. The number of studies using the microarray technology is logarithmically in-
creasing. Thus, this technology is becoming a standard laboratory technique. Here, we introduce some suc-
cessful microarray studies in relation to allergic diseases, and discuss why these authors succeeded, and dis-
cuss the strategy for microarray studies from data generation to data analysis.
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INTRODUCTION
Recent advances in technology such as gene-
targeting animal models or cultivation of single cell
types enable us to understand the pathology of aller-
gic diseases at molecular levels. However, it had not
been possible to examine the levels of total molecules
playing some roles in these diseases, especially re-
garding the whole protein molecules present in a cell
or a body (the proteome). Microarrays, also called
DNA chips, were first lauded in public by former USA
President Clinton in his State-of-the-Union address in
1999,1 and then have attracted tremendous interest
among biologists and industries . Microarrays have
been mainly used to examine the transcriptome (the
whole transcripts present in a cell or a body) , al-
though some microarrays are now becoming avail-
able for detecting whole genetic variations present in
the genome. The application of microarrays to the
proteome is not yet practical when considering its
meaning (the whole protein information present in a
cell or a body) . In contrast, the number of studies us-
ing the microarray technology for the transcriptome
is logarithmically increasing. Thus, this technology is
becoming a standard laboratory technique. Here, we
introduce some successful microarray studies in rela-
tion to allergic diseases and discuss why these
authors succeeded．
GUIDELINES FOR MICROARRAY STUDIES
Microarray technologies can be classified into two
types . One consists of oligonucleotide microarrays
that use synthesized oligonucleotide as probes, while
the other consists of cDNA microarrays that use
whole cDNA molecules with irregular lengths as
probes. Compared with oligonucleotide microarrays,
the results of cDNA microarray assays are less repro-
ducible because both the target RNA and probe sizes
are irregular, resulting in variable binding capacity.2
Thus, questions were raised in 2002 regarding the re-
producibility of studies performed using microarrays,
especially for cDNA microarrays.3 Then, a document
was generated outlining the minimal information that
should be reported about a microarray experiment to
enable its unambiguous interpretation and reproduc-
tion when submitting a microarray study to most
journals ( http:www.mged .orgWorkgroupsMI-
AMEmiame_checklist .html).4 The guidelines de-
mand the investigators to describe the following six
factors, i.e., experimental design, array design, sam-
ple types , hybridization methods , measurement
methods, and normalization controls, in detail when
submitting reports to journals (MGED Guide to
authors, editors and reviewers of microarray gene ex-
pression papers). These microarray guidelines aim
mainly at reproducing the results obtained using
cDNA microarrays that had been hand-made in indi-
Allergology International. 2005;54:345-349
REVIEW ARTICLE
1Department of Allergy and Immunology, National Research Insti-
tute for Child Health & Development, Tokyo, Japan.
Correspondence: Hirohisa Saito, M.D., Ph.D., Department of Al-
lergy and Immunology, National Research Institute for Child
Health & Development, 2−10−1 Okura, Setagaya-ku, Tokyo 157−
8535, Japan.
Email: hsaito@nch.go.jp
Received 30 March 2005.
2005 Japanese Society of Allergology
Allergology International Vol 54, No3, 2005 www.js-allergol.gr.jp 345
vidual laboratories. For the microarray studies deal-
ing with inflammatory tissues as in the field of al-
lergy, the journal Arthritis and Rheumatism gener-
ated its own guideline .5 These criteria were as fol-
lows : (1) Reproducibility must be demonstrated, in-
cluding rigorous evaluation of the run-to-run variabil-
ity for each gene. (2) Detailed statistical analysis is
required , including appropriate corrections for re-
peated or multiple measurements. (3) Homogeneous
cell populations should optimally be studied, to re-
duce the complexity of analysis . (4) A non-array
method must confirm changes in the expression of
key genes. These guidelines are applied to both types
of microarrays．
EXPERIMENTS USING WELL-CONTROLLED
ANIMAL MODELS
Most successful microarray-based results, especially
in allergy-related fields, have been obtained in studies
dealing with well-controlled animal model experi-
ments. For example, Karp et al.6 obtained eight new
strains of mice by crossing AJ mice, which tend to
have antigen-specific airway hypersensitivity , with
C3HHeJ mice. They used GeneChip (Affymetrix ,
Santa Clara, CA, USA) , an oligonucleotide microar-
ray platform, to examine >7000 genes expressed in
the lungs after sensitization and challenge with aller-
gens . They found that a genetic polymorphism of
complement C5a, known to induce mast cell degranu-
lation, was associated with the allergen-induced air-
way hypersensitivity. Zimmerman et al. 7 created an
asthma model by sensitizing Balbc mice with OVA
and Aspergillus fumigatus and used GeneChip to ana-
lyze the lungs of these mice and controls after aller-
gen challenge . As a result , they found 291 genes
whose expression levels were commonly increased
by challenge with both antigens. Among those genes,
arginase I, arginase II and cationic acid transporter 2
were found to be dramatically increased. They sug-
gested the importance of these molecules in the pa-
thology of asthma by showing that they were also
highly expressed in human asthmatic airway epithe-
lium. It should be noted that these two groups have
confirmed their results to be highly reproducible by
comparing two samples after allergen challenge from
each experimental condition.
EXPERIMENTS USING A CULTURED PURE
CELL TYPE
There have been many successful microarray studies
using cultured cells with or without stimulation .
Yuyama et al. applied microarray analyses to find
genes regulated by IL-4 and IL-13 in human bronchial
epithelial cells. They identified a subset of disease-
relevant genes, squamous cell carcinoma antigen-1
(SCCA1) and SCCA2, the cysteine and serine pro-
tease inhibitors by comparison with cDNA libraries
derived from normal and asthmatic bronchial biop-
sies.8 Qiao et al. used microarray to identify 8 upregu-
lated genes in differentiated (type I) alveolar epithe-
lial cells compared with type II primary type cells .
They confirmed three of these genes, PAI-1, P2X4,
and P15INK4B by using Northern blotting analysis
and Western blotting analysis for corresponding pro-
teins.9 Zhang et al. also used oligonucleotide microar-
ray to examine the effect of anti-viral agent ribavirin
on gene expression in respiratory syncytial virus-
infected human A549 pulmonary type II epithelial
cells. They found that ribavirin up-regulated the tran-
scriptional activity of a reporter gene selectively
driven by the IFN-stimulated response element
(ISRE), indicating the enhancement of IFN-related
anti-viral proteins by the drug.10 Cho et al. used oli-
gonucleotide microarray to examine the up-regulated
genes in activated human mast cells, and identified
activin A to be one of the most up-regulated genes.
Activin A was found to be expressed equally by
mouse mast cells. They found that mast cell-derived
activin A play an important role in airway smooth
muscle cell hypertrophy by measuring activin A lev-
els in asthma model mice and mast cell-deficient W
Wv mice.11
Wang et al. 12 and Okumura et al. 13 used oligonu-
cleotide microarray to examine the up-regulated
genes expressed by activated mast cells. These two
groups separately identified amphiregulin as a tran-
script that is markedly increased following aggrega-
tion of FcεRI. Amphiregulin induced tissue remodel-
ing, i.e., proliferation of lung fibroblasts and marked
induction of MUC5AC transcripts in a human respira-
tory epithelial cell line . Both groups showed that
amphiregulin-positive mast cells are increased in the
airways of asthmatics. These investigators employed
culture-derived human mast cells for microarray as
the first screening and confirmed the in vivo expres-
sion and function of this up-regulated gene using hu-
man tissue samples．
Thus, microarray experiments seem to be highly
reproducible when well-controlled animal models or
pure cells are employed．
EXPERIMENTS USING MIXED CELL POPU-
LATIONS
The gene expression levels obtained using GeneChip
are usually between 1 and approximately 25,000.
However, the expression levels of certain abundantly
or scantly expressed genes do not show linear rela-
tionships, so that the actual dynamic range is consid-
ered to be only 102. In our early GeneChip study us-
ing human clinical samples, we identified several in-
creased transcripts in peripheral blood mononuclear
cells (PBMC) obtained from severe atopic patients by
calculating the ratio of their expression levels.14 How-
ever, the ratio should have been more carefully calcu-
lated when the values were small even when accom-
panied by the presence call, which means an analysis
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Fig. 1　A scater plot of gene expression levels of CD4+ T 
cels from two normal donors (sample ID #676 and #686) on 
GeneChip U133A Arays (Afymetrix). Black dots represent 
genes expressed with presence cals in at least either one 
sample and gray dots represent genes expressed with ab-
sence or marginal cals in both samples. Brain-type PGD2 
synthase (PGDS) was highly expressed by only one donor 
CD4 sample, while C5aR was only expressed with a pres-
ence cal by another sample. Since C5aR is judged to be 
specific in granulocytes 20 and PGDS is selectively ex-
pressed by NK cels compared with other cel types (unpu-
blished observation), these transcripts may be artifactualy 
present among the whole CD4 population. The experimen-
tal design was previously described by us.20
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that is statistically significant. Increased transcripts in
PBMC included defensin-1 and ribosomal protein L
37. However , these genes may have been derived
from contamination of the PBMC population by baso-
phils, because our recent results regarding cell type-
specific transcriptome data15 found these genes to be
highly expressed by basophils. Thus, contamination
by a very small population of a different cell type hav-
ing a certain highly expressed transcript may cause
an artifactual presence of the transcript in the whole
population even where the major cell type lacks it
(Fig. 1).
Changes in cell populations are especially crucial in
microarray analysis of tissues characterized by re-
cruitment of inflammatory cells. Indeed, arginase I is
highly expressed by neutrophils among the human
leukocyte types. Up-regulation of transcriptional lev-
els in a crude tissue is often simply caused by an in-
crease in recruitment of a certain inflammatory cell
type. Therefore, in order to avoid difficulty in inter-
preting the results, it is important, for comparison, to
purify the target cell population as much as possible.
However, mRNA is unstable , meaning that compli-
cated procedures for purification should be avoided．
Guajardo et al. have recently succeeded in identify-
ing nasal epithelial-specific up-regulated genes by dif-
ferentiating the cell types obtained by scraping the
nasal membranes of allergic rhinitics.16
However, computational identification of the cell-
type specificity may be preferable when a certain im-
portant transcript is found in crude tissue samples
when cell types can not be identified. For such pur-
pose, microarray data may be used by downloading
from a public on-line database．
USE OF PUBLIC DATABASES AND BIOIN-
FORMATICS
It has been useful and is becoming increasingly nec-
essary to obtain microarray data from public data-
bases , especially for comparison of a certain tran-
script with other cell types. Regarding asthmatic CD4
T cells, all the microarray data can be downloaded
from Gene Expression Omnibus (GEO; http:www.
ncbi.nlm.nih.govgeo). The experiments were done
using oligonucleotide microarrays ( Affymetrix
GeneChip U133A) and CD4 T cells obtained from 5
patients with severe asthma, 15 patients with mild
asthma and 6 controls. The Laboratory for System Bi-
ology and Medicine at the University of Tokyo have
made available the microarray data of 55 different
types of human tissue cell types which were obtained
using Affymetrix GeneChip U133A ( http:www.
lsbm.orgsite_eindex.html). It is possible to com-
bine the data obtained from public databases and our
own data. For analyzing large-scale gene expression
data, hierarchical clustering analysis is becoming a
common laboratory technique.17,18 Such a clustering
tool can be freely obtained at http:rana. lbl .gov
EisenSoftware.htm. It should be noted that clustering
analysis is just bringing one of the possibilities to pro-
file the data but not a statistical significance to the re-
sults . Kaminski and Friedman have introduced in
their review article19 some methods for identifying
genes with statistically significant changes in gene
expression. Statistical calculation will be required af-
ter suitable normalization of data obtained from dif-
ferent laboratories.
APPLICATIONS TO SYSTEM BIOLOGY
cDNA microarrays which use largely unknown se-
quences or differential display PCR which uses ran-
dom primers had been useful for searching unidenti-
fied genes compared with oligonucleotide microar-
rays which use synthesized oligonucleotides with
known sequences as probes. However, after complete
sequencing of the human genome or mouse genome,
we understand that the number of genes is limited to
only <30,000. One of the oligonucleotide microarrays,
GeneChip, covers the measurement of >45,000 tran-
scripts at once. That means that we have obtained a
tool which can measure nearly the total“ transcrip-
tome”．
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Microarray studies have been appreciated as a tool
which can measure large-scale gene expression at
once. However, this is changing now that the tool for
understanding all transcriptional information has
been obtained. Now, we may say that there is nothing
left in the genome. It will soon be applied to pharma-
ceutical development. For example, theoretically, we
will be able to predict all transcripts related to an ad-
verse effect of a certain drug, and change the drug
structure in order to avoid it. For example, we have
identified mast cell-, eosinophil- and basophil-specific
transcripts, which are expected to be potential thera-
peutic targets for allergic diseases because these
cells play crucial roles in allergic inflammation.20 A
certain gene that is highly expressed in mast cells,
for example , can be easily found by searching the
mast cell transcriptome. Comparison with the tran-
scriptomes expressed by other cell types, however,
may reveal that said gene is not truly mast cell-
specific. Thus, it is especially important to elucidate
information regarding the cell type-specificity when
developing a new drug. Such information may help to
predict drug-related adverse events caused by inter-
action of a drug with responsible molecules present
in important organs. In the future, the safety of candi-
date drugs could be evaluated by comparing their ef-
ficacy on these granulocytes with their toxicity to vital
organs．
The increasing prevalence of allergic diseases in
developed countries is considered by many to be
caused, at least in part, by rapid improvement of hy-
giene. In human beings, the immune system devel-
oped as an ingenious device for defending against fre-
quent attacks by microbes. Therefore, our immune
system seems to have become deranged in our re-
cent, unprecedented hygienic environment. It is now
necessary to understand all functional elements com-
prising the immune system, not just a single mole-
cule present in an immunocyte working in our im-
mune system. Until now, microarrays have been used
as a high-throughput assay method . However , it
should be stressed that microarrays can detect whole
transcripts present in a cell and can be used for un-
derstanding system biology.21 It is anticipated that as
this and related technology continues to advance, it
will help our understanding of deranged human im-
munity as a system.
CONCLUSION
Here, we have introduced some successful microar-
ray studies. Rapid advances in microarray technolo-
gies and the related computational analyses have led
to a paradigm shift in biological investigation, such
that the bottleneck in research is shifting from data
generation to data analysis. As Kaminski and Fried-
man described,19 one of the most painful stages in the
analysis of the results of microarray experiments is
the postcomputational stage. There is no final resolu-
tion for this stage in the analysis. Moreover, microar-
ray results often demand more knowledge about
medicine and biology from us than before. Therefore,
collaboration is necessary by sharing large-scale data
which may bring different answers to each investiga-
tor working in different research fields．
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